These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11851579)

  • 1. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant.
    Freedman A; Afonja O; Chang MW; Mostashari F; Blaser M; Perez-Perez G; Lazarus H; Schacht R; Guttenberg J; Traister M; Borkowsky W
    JAMA; 2002 Feb; 287(7):869-74. PubMed ID: 11851579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City.
    Mina B; Dym JP; Kuepper F; Tso R; Arrastia C; Kaplounova I; Faraj H; Kwapniewski A; Krol CM; Grosser M; Glick J; Fochios S; Remolina A; Vasovic L; Moses J; Robin T; DeVita M; Tapper ML
    JAMA; 2002 Feb; 287(7):858-62. PubMed ID: 11851577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From the Centers for Disease Control and Prevention. Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    JAMA; 2001 Nov; 286(17):2086-8. PubMed ID: 11757496
    [No Abstract]   [Full Text] [Related]  

  • 4. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Images in clinical medicine. Cutaneous anthrax infection.
    Roche KJ; Chang MW; Lazarus H
    N Engl J Med; 2001 Nov; 345(22):1611. PubMed ID: 11704684
    [No Abstract]   [Full Text] [Related]  

  • 6. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous anthrax: an overview.
    Celia F
    Dermatol Nurs; 2002 Apr; 14(2):89-92. PubMed ID: 12017087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention
    JAMA; 2001 Nov; 286(19):2392-6. PubMed ID: 11759667
    [No Abstract]   [Full Text] [Related]  

  • 10. From the Centers for Disease Control and Prevention. Public health dispatch: update: cutaneous anthrax in a laboratory worker-Texas, 2002.
    JAMA; 2002 Jul 24-31; 288(4):444. PubMed ID: 12141318
    [No Abstract]   [Full Text] [Related]  

  • 11. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: Cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(22):482. PubMed ID: 12064454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax.
    Shieh WJ; Guarner J; Paddock C; Greer P; Tatti K; Fischer M; Layton M; Philips M; Bresnitz E; Quinn CP; Popovic T; Perkins BA; Zaki SR;
    Am J Pathol; 2003 Nov; 163(5):1901-10. PubMed ID: 14578189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated case of bioterrorism-related inhalational anthrax, New York City, 2001.
    Holtz TH; Ackelsberg J; Kool JL; Rosselli R; Marfin A; Matte T; Beatrice ST; Heller MB; Hewett D; Moskin LC; Bunning ML; Layton M
    Emerg Infect Dis; 2003 Jun; 9(6):689-96. PubMed ID: 12781008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous anthrax.
    Godyn JJ; Siderits R; Dzaman J
    Arch Pathol Lab Med; 2004 Jun; 128(6):709-10. PubMed ID: 15163220
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001.
    JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482
    [No Abstract]   [Full Text] [Related]  

  • 17. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related Anthrax--Connecticut, 2001.
    JAMA; 2002 Jan; 287(1):34-5. PubMed ID: 11797623
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis: cutaneous anthrax.
    Doğanay M; Aygen B
    Clin Infect Dis; 1997 Sep; 25(3):607, 725. PubMed ID: 9314446
    [No Abstract]   [Full Text] [Related]  

  • 19. [Female patient with cutaneous anthrax in Belgium].
    Gyssens IC; Weyns D; Kullberg BJ; Ursi JP
    Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2386-8. PubMed ID: 11770267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of cutaneous anthrax.
    Suchard JR
    JAMA; 2002 Jul; 288(1):43; author reply 44. PubMed ID: 12090858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.